142 related articles for article (PubMed ID: 35432534)
1. Expression Profiles of HOXC6 Predict the Survival of Glioblastoma Patients and Correlate with Cell Cycle.
Li ZH; Ma Y; Zhou Y; Huang ZH
J Oncol; 2022; 2022():8656865. PubMed ID: 35432534
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of HOXC6 promotes cell proliferation and migration via MAPK signaling and predicts a poor prognosis in glioblastoma.
Yang P; Kang W; Pan Y; Zhao X; Duan L
Cancer Manag Res; 2019; 11():8167-8179. PubMed ID: 31564976
[TBL] [Abstract][Full Text] [Related]
3. HOXC6/8/10/13 predict poor prognosis and associate with immune infiltrations in glioblastoma.
Yu M; Yu S; Zhou W; Yi B; Liu Y
Int Immunopharmacol; 2021 Dec; 101(Pt A):108293. PubMed ID: 34763232
[TBL] [Abstract][Full Text] [Related]
4. The Effects of Differentially-Expressed Homeobox Family Genes on the Prognosis and HOXC6 on Immune Microenvironment Orchestration in Colorectal Cancer.
Qi L; Ye C; Zhang D; Bai R; Zheng S; Hu W; Yuan Y
Front Immunol; 2021; 12():781221. PubMed ID: 34950145
[TBL] [Abstract][Full Text] [Related]
5. Establish six-gene prognostic model for glioblastoma based on multi-omics data of TCGA database.
Lei CG; Jia XY; Sun WJ
Yi Chuan; 2021 Jul; 43(7):665-679. PubMed ID: 34284982
[TBL] [Abstract][Full Text] [Related]
6. A robust two-gene signature for glioblastoma survival prediction.
Pan Y; Zhang JH; Zhao L; Guo JC; Wang S; Zhao Y; Tao S; Wang H; Zhu YB
J Cell Biochem; 2020 Jul; 121(7):3593-3605. PubMed ID: 31960992
[TBL] [Abstract][Full Text] [Related]
7. Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients.
Gao WZ; Guo LM; Xu TQ; Yin YH; Jia F
J Transl Med; 2018 Dec; 16(1):368. PubMed ID: 30572911
[TBL] [Abstract][Full Text] [Related]
8. An Immune-Related Six-lncRNA Signature to Improve Prognosis Prediction of Glioblastoma Multiforme.
Zhou M; Zhang Z; Zhao H; Bao S; Cheng L; Sun J
Mol Neurobiol; 2018 May; 55(5):3684-3697. PubMed ID: 28527107
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of HOXC6 inhibits glioma cell proliferation and induces cell cycle arrest by targeting WIF-1 in vitro and vivo.
Yan TF; Wu MJ; Xiao B; Hu Q; Fan YH; Zhu XG
Pathol Res Pract; 2018 Nov; 214(11):1818-1824. PubMed ID: 30228024
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing.
Fan F; Zhang H; Dai Z; Zhang Y; Xia Z; Cao H; Yang K; Hu S; Guo Y; Ding F; Cheng Q; Zhang N
Cell Oncol (Dordr); 2021 Aug; 44(4):917-935. PubMed ID: 34142341
[TBL] [Abstract][Full Text] [Related]
11. HOXC6 Overexpression Is Associated With Ki-67 Expression and Poor Survival in NPC Patients.
Chang SL; Chan TC; Chen TJ; Lee SW; Lin LC; Win KT
J Cancer; 2017; 8(9):1647-1654. PubMed ID: 28775784
[No Abstract] [Full Text] [Related]
12. Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct Prognoses.
Liu YQ; Wu F; Li JJ; Li YF; Liu X; Wang Z; Chai RC
Front Oncol; 2019; 9():1433. PubMed ID: 31921684
[No Abstract] [Full Text] [Related]
13. HOXC6 Regulates the Epithelial-Mesenchymal Transition through the TGF-
Eryi S; Zheng L; Honghua C; Su Z; Han X; Donggang P; Zhou Z; Liping Z; Bo C
J Oncol; 2022; 2022():8016102. PubMed ID: 35571491
[TBL] [Abstract][Full Text] [Related]
14. Identification of biomarkers and ceRNA network in glioblastoma through bioinformatic analysis and evaluation of potential prognostic values.
Hong F; Gong Z; Zhang X; Ma P; Yin Y; Wang H
Ann Transl Med; 2021 Oct; 9(20):1561. PubMed ID: 34790767
[TBL] [Abstract][Full Text] [Related]
15. A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma.
Chai R; Zhang K; Wang K; Li G; Huang R; Zhao Z; Liu Y; Chen J
J Cancer Res Clin Oncol; 2018 Mar; 144(3):439-447. PubMed ID: 29299749
[TBL] [Abstract][Full Text] [Related]
16. Identification of a Five-mRNA Signature as a Novel Potential Prognostic Biomarker for Glioblastoma by Integrative Analysis.
Xu H; Zhang L; Xia X; Shao W
Front Genet; 2022; 13():931938. PubMed ID: 35873480
[TBL] [Abstract][Full Text] [Related]
17. HOXC6 impacts epithelial-mesenchymal transition and the immune microenvironment through gene transcription in gliomas.
Huang H; Huo Z; Jiao J; Ji W; Huang J; Bian Z; Xu B; Shao J; Sun J
Cancer Cell Int; 2022 Apr; 22(1):170. PubMed ID: 35488304
[TBL] [Abstract][Full Text] [Related]
18. Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme.
Yang J; Wang L; Xu Z; Wu L; Liu B; Wang J; Tian D; Xiong X; Chen Q
Front Genet; 2020; 11():253. PubMed ID: 32296458
[TBL] [Abstract][Full Text] [Related]
19. Molecular and Clinicopathological Characterization of a Prognostic Immune Gene Signature Associated With MGMT Methylation in Glioblastoma.
Zhao L; Zhang J; Xuan S; Liu Z; Wang Y; Zhao P
Front Cell Dev Biol; 2021; 9():600506. PubMed ID: 33614641
[No Abstract] [Full Text] [Related]
20. Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis.
Kim YW; Koul D; Kim SH; Lucio-Eterovic AK; Freire PR; Yao J; Wang J; Almeida JS; Aldape K; Yung WK
Neuro Oncol; 2013 Jul; 15(7):829-39. PubMed ID: 23502430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]